PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 15144225-6 2004 This benzo[a]pyrene-induced osteoblast proliferation could be inhibited by the estrogen receptor antagonist ICI182780 and tamoxifen, PD98059 [extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) inhibitor], and LY294002 [phosphatidylinositol 3-kinase (PI3K) inhibitor] but not alpha-naphthoflavone (aryl hydrocarbon receptor antagonist) and SB203580 (p38 MAPK inhibitor). pyrene 13-19 mitogen-activated protein kinase 1 Homo sapiens 142-179 17908424-0 2007 [c-Jun NH2-terminal kinase and extracellular signal-regulated protein kinase signaling pathways in regulation of benzo(a)pyrene-induced c-Jun activation in human embryo lung fibroblasts]. pyrene 121-127 mitogen-activated protein kinase 1 Homo sapiens 31-76 16600107-0 2006 [ERK and JNK/AP-1 pathways involved in benzo(a)pyrene induced cell cycle changes in human embryo lung fibroblasts]. pyrene 47-53 mitogen-activated protein kinase 1 Homo sapiens 1-4 10548541-9 1999 Recombinant ERK was found to co-sediment with purified actin and induced a fluorescence change in pyrene-labelled F-actin (K(a)=5x10(6) M(-1)). pyrene 98-104 mitogen-activated protein kinase 1 Homo sapiens 12-15 15144225-6 2004 This benzo[a]pyrene-induced osteoblast proliferation could be inhibited by the estrogen receptor antagonist ICI182780 and tamoxifen, PD98059 [extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) inhibitor], and LY294002 [phosphatidylinositol 3-kinase (PI3K) inhibitor] but not alpha-naphthoflavone (aryl hydrocarbon receptor antagonist) and SB203580 (p38 MAPK inhibitor). pyrene 13-19 mitogen-activated protein kinase 1 Homo sapiens 181-184